How the Birth Control Pill Got Over the Counternews2023-07-20T06:17:28+00:00July 20th, 2023|The New York Times|
Over-the-Counter Birth Control Pills Are Coming. What’s Next?news2023-07-19T09:00:27+00:00July 19th, 2023|The New York Times|
How Women Feel About an Over-the-Counter Birth Control Pillnews2023-07-15T00:34:02+00:00July 15th, 2023|The New York Times|
Leqembi: lo que hay que saber sobre el fármaco contra el alzhéimernews2023-07-08T11:00:12+00:00July 8th, 2023|The New York Times|
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDAnews2023-07-06T22:20:07+00:00July 6th, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
How the Shortage of a $15 Cancer Drug Is Upending Treatmentnews2023-06-26T15:47:37+00:00June 26th, 2023|The New York Times|
La FDA aprueba Eroxon, un gel contra la disfunción eréctilnews2023-06-23T23:29:32+00:00June 23rd, 2023|The New York Times|
Erectile Dysfunction Treatment: What to Know About Eroxon, a New Topical Gelnews2023-06-21T16:30:47+00:00June 21st, 2023|The New York Times|
